4//SEC Filing
Higgons John Duncan 4
Accession 0001640455-21-000074
CIK 0001640455other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 8:46 PM ET
Size
4.7 KB
Accession
0001640455-21-000074
Insider Transaction Report
Form 4
Higgons John Duncan
Director
Transactions
- Sale
Common Stock
2021-04-15$10.00/sh−200$2,000→ 9,713 total
Footnotes (1)
- [F1]The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2020. The Reporting Person exercised no discretion with respect to this transaction.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001581954
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 8:46 PM ET
- Size
- 4.7 KB